What is Isobide used for?

Isobide is indicated for Ocular hypertension.

Isobide is developed by Alvogen Korea.

What development phase is Isobide in?

Isobide is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Isobide

Alvogen Korea · FDA-approved active Small molecule Quality 9/100

At a glance

Generic name	Isobide
Sponsor	Alvogen Korea
Modality	Small molecule
Therapeutic area	Cardiovascular
Phase	FDA-approved

Approved indications

Ocular hypertension

Common side effects

No common side effects on file.

Key clinical trials

Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Isobide CI brief — competitive landscape report
Isobide updates RSS · CI watch RSS
Alvogen Korea portfolio CI